James Warren Huff - Net Worth and Insider Trading
James Warren Huff Net Worth
The estimated net worth of James Warren Huff is at least $5 Million dollars as of 2024-03-28. James Warren Huff is the CEO of Reata Pharmaceuticals Inc and owns about 28,166 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $5 Million. Details can be seen in James Warren Huff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Warren Huff has not made any transactions after 2020-11-10 and currently still holds the listed stock(s).
Transaction Summary of James Warren Huff
James Warren Huff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Warren Huff owns 1 companies in total, including Reata Pharmaceuticals Inc () .
Click here to see the complete history of James Warren Huff’s form 4 insider trades.
Insider Ownership Summary of James Warren Huff
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Reata Pharmaceuticals Inc | 2020-11-10 | director & See Remarks |
James Warren Huff Latest Holdings Summary
James Warren Huff currently owns a total of 1 stock. James Warren Huff owns 28,166 shares of Reata Pharmaceuticals Inc (RETA) as of November 10, 2020, with a value of $5 Million.
Latest Holdings of James Warren Huff
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RETA | Reata Pharmaceuticals Inc | 2020-11-10 | 28,166 | 172.36 | 4,854,692 |
Holding Weightings of James Warren Huff
James Warren Huff Form 4 Trading Tracker
According to the SEC Form 4 filings, James Warren Huff has made a total of 2 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 81,657 shares on November 10, 2020, which brought James Warren Huff around $14 Million.
Insider Trading History of James Warren Huff
- 1
James Warren Huff Trading Performance
GuruFocus tracks the stock performance after each of James Warren Huff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Warren Huff is 32.73%. GuruFocus also compares James Warren Huff's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Warren Huff within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Warren Huff's insider trading performs compared to the benchmark.
Performance of James Warren Huff
Average Relative Return
104.9%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | 39.79 | 32.73 | 75.45 | 104.9 | 57.63 | 81.44 |
Relative Return to S&P 500(%) | 39.62 | 29.32 | 71.08 | 89.15 | 43.5 | 71.99 |
James Warren Huff Ownership Network
Ownership Network List of James Warren Huff
Ownership Network Relation of James Warren Huff
James Warren Huff Owned Company Details
What does Reata Pharmaceuticals Inc do?
Who are the key executives at Reata Pharmaceuticals Inc?
James Warren Huff is the director & See Remarks of Reata Pharmaceuticals Inc. Other key executives at Reata Pharmaceuticals Inc include director & 10 percent owner Antal Rohit Desai , SVP & Chief Accounting Officer Bhaskar Anand , and EVP & Chief R&D Officer Rajiv Patni .
Reata Pharmaceuticals Inc () Insider Trades Summary
Over the past 18 months, James Warren Huff made no insider transaction in Reata Pharmaceuticals Inc (). Other recent insider transactions involving Reata Pharmaceuticals Inc () include a net sale of 185,892 shares made by Manmeet Singh Soni , a net sale of 150,995 shares made by Dawn Carter Bir , and a net sale of 2,880 shares made by Bhaskar Anand .
In summary, during the past 3 months, insiders sold 0 shares of Reata Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 530,967 shares of Reata Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 530,967 shares.
Reata Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Reata Pharmaceuticals Inc Insider Transactions
James Warren Huff Mailing Address
Above is the net worth, insider trading, and ownership report for James Warren Huff. You might contact James Warren Huff via mailing address: C/o Reata Pharmaceuticals, Inc., 2801 Gateway Dr. Suite 150, Irving Tx 75063.